First Dallas Securities Inc. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 216 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
First Dallas Securities Inc. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$229,000
-20.5%
11,250
-40.5%
0.18%
-24.0%
Q1 2016$288,000
+6.3%
18,900
-6.4%
0.23%
+5.0%
Q4 2015$271,000
-9.7%
20,200
-5.4%
0.22%
-10.1%
Q3 2015$300,000
-9.1%
21,350
+9.8%
0.25%
+3.8%
Q2 2015$330,00019,4500.24%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders